REPATRIATION MEDICAL AUTHORITY
INSTRUMENT NO. 53 of 2008
VETERANS’ ENTITLEMENTS ACT 1986
MILITARY REHABILITATION AND COMPENSATION ACT 2004
EXPLANATORY NOTES FOR TABLING
- The Repatriation Medical Authority (the Authority), under subsection 196B(8) of the Veterans’ Entitlements Act 1986 (the VEA) revokes Instrument No. 12 of 1999, determined under subsection 196B(3) of the VEA concerning hepatitis B and death from hepatitis B.
2. The Authority is of the view that on the sound medical-scientific evidence available it is more probable than not that hepatitis B and death from hepatitis B can be related to particular kinds of service. The Authority has therefore determined pursuant to subsection 196B(3) of the VEA a Statement of Principles, Instrument No. 53 of 2008 concerning hepatitis B. This Instrument will in effect replace the revoked Statement of Principles.
3. The provisions of the Military Rehabilitation and Compensation Act 2004 (the MRCA) relating to claims for compensation commenced on 1 July 2004. Claims under section 319 of the MRCA for acceptance of liability for a service injury sustained, a service disease contracted or service death on or after 1 July 2004 are determined by the Military Rehabilitation and Compensation Commission by reference to Statements of Principles issued by the Authority pursuant to the VEA.
4. The Statement of Principles sets out the factors that must exist, and which of those factors must be related to the following kinds of service rendered by a person:
eligible war service (other than operational service) under the VEA;
defence service (other than hazardous service) under the VEA;
peacetime service under the MRCA,
before it can be said that, on the balance of probabilities, hepatitis B or death from hepatitis B is connected with the circumstances of that service.
5. This new instrument results from an investigation notified by the Authority in the Government Notices Gazette of 8 November 2006 concerning hepatitis B in accordance with section 196G of the VEA. The investigation involved an examination of the sound medical-scientific evidence now available to the Authority, including the sound medical-scientific evidence it has previously considered.
6. The contents of the new Instrument are in similar terms as the revoked Instrument. Comparing the new and the revoked Instruments, the differences include:
- adopting the latest revised Instrument format, which commenced in 2005;
- deleting the ICD code from the Instrument header;
- revising the definition of 'hepatitis B' in clause 3;
- revising factor 6(a) concerning 'recent infection' now using the term 'acute infection';
- revising factor 6(b) concerning 'non-recent infection' now using the term 'chronic infection';
- inserting new factor 6(c) concerning 'being in an area where the prevalence of hepatitis B is at least 2%';
- inserting new factor 6(d) concerning 'immunosuppressed state';
- inserting new factor 6(e) concerning 'therapeutic radiation to the region of the liver';
- inserting new factor 6(f) concerning 'being infected with hepatitis A, hepatitis C, hepatitis D or hepatitis E';
- inserting new factor 6(g) concerning 'alcohol';
- inserting new definitions of "a course of therapeutic radiation", "a specified body substance", "being exposed to the hepatitis B virus", "being in an immunosuppressed state", and "ICD-10-AM code" in clause 9;
- revising definition of "relevant service" in clause 9;
- deleting definitions of "blood product injection", "body fluids", "evidence of non-recent infection", "evidence of recent infection", "ICD-9-CM code", "parenteral drug user", and "sexual intercourse"; and
- specifying a date of effect for the Instrument in clause 11.
7. Further changes to the format of the Instrument reflect the commencement of the MRCA and clarify that pursuant to subsection 196B(3A) of the VEA, the Statement of Principles has been determined for the purposes of both the VEA and the MRCA.
8. Prior to determining this instrument, the Authority advertised its intention to undertake an investigation in relation to hepatitis B in the Government Notices Gazette of 8 November 2006, and circulated a copy of the notice of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants. The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field. No submissions were received for consideration by the Authority during the investigation.
9. The determining of this new instrument finalises the investigation in relation to hepatitis B as advertised in the Government Notices Gazette of 8 November 2006.
10. A list of references relating to the above condition is available, on written request, from the Repatriation Medical Authority Secretariat.